BioVie Statistics
Total Valuation
BioVie has a market cap or net worth of $17.80 million. The enterprise value is -$4.98 million.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioVie has 18.54 million shares outstanding. The number of shares has increased by 199.08% in one year.
| Current Share Class | 18.54M |
| Shares Outstanding | 18.54M |
| Shares Change (YoY) | +199.08% |
| Shares Change (QoQ) | +17.75% |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 5.87% |
| Float | 16.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.81 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.32, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.32 |
| Quick Ratio | 9.09 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.00 |
Financial Efficiency
Return on equity (ROE) is -93.23% and return on invested capital (ROIC) is -48.44%.
| Return on Equity (ROE) | -93.23% |
| Return on Assets (ROA) | -42.51% |
| Return on Invested Capital (ROIC) | -48.44% |
| Return on Capital Employed (ROCE) | -86.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.38M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.27% in the last 52 weeks. The beta is 1.11, so BioVie's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -76.27% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.69 |
| Relative Strength Index (RSI) | 42.73 |
| Average Volume (20 Days) | 210,201 |
Short Selling Information
The latest short interest is 1.23 million, so 6.62% of the outstanding shares have been sold short.
| Short Interest | 1.23M |
| Short Previous Month | 1.45M |
| Short % of Shares Out | 6.62% |
| Short % of Float | 7.62% |
| Short Ratio (days to cover) | 4.98 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.19M |
| Pretax Income | -36.29M |
| Net Income | -19.36M |
| EBITDA | -18.96M |
| EBIT | -19.19M |
| Earnings Per Share (EPS) | -$1.66 |
Full Income StatementBalance Sheet
The company has $23.15 million in cash and $366,430 in debt, giving a net cash position of $22.79 million or $1.23 per share.
| Cash & Cash Equivalents | 23.15M |
| Total Debt | 366,430 |
| Net Cash | 22.79M |
| Net Cash Per Share | $1.23 |
| Equity (Book Value) | 21.82M |
| Book Value Per Share | 1.18 |
| Working Capital | 21.17M |
Full Balance SheetCash Flow
| Operating Cash Flow | -17.42M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
